Aging, arterial stiffness, and hypertension.

Although the etiology of essential hypertension remains unknown, it is clear that multiple factors may contribute to the pathogenesis of hypertension. Hypertension is an outcome of the interaction of multiple genetic and environmental factors. Several epidemiological studies indicated that the incidence of arterial stiffness and hypertension and related cardiovascular disease (stroke, myocardial infarction) is higher in the aged than in the young population.1–4 The prevalence of arterial stiffening and hypertension increases with age.1,5 Based on an epidemiological study,6 the prevalence of hypertension is more than doubled in the elderly than in the young population. More than two-thirds of individuals after 65 years of age experience hypertension according to the Seventh Report of the Joint National Committee (JNC-7).7 Therefore, it is generally thought that hypertension is an aging disorder. In recent years, metabolic syndrome and hypertension are increasingly seen in the middle-aged and young populations. In these subpopulations, insulin resistance and overproduction of adipokines impair endothelial and heart function leading to early and accelerated cardiovascular aging. It was reported that premature aging (progeria) is associated with accelerated vascular stiffening or vascular aging.8 Aging is defined as the age-related decline in physiological function essential for survival and fertility. Cardiovascular aging is an important factor that determines life span. The wall of large conduit arteries, especially aorta, thicken and lose elasticity over time, and this process results in an increase in pulse wave velocity, an important and reliable measure of arterial stiffness. The increased arterial stiffness, whatever its underlying causes, would reduce the reservoir/buffering function of the conduit arteries near the heart and increase pulse wave velocity, both of which increase systolic and pulse pressure. Therefore, aging-related hypertension is characterized by a significant increase in systolic blood pressure with no change or even a …

[1]  J. Sowers Diabetes mellitus and vascular disease. , 2013, Hypertension.

[2]  D. Kitzman,et al.  Carotid Arterial Stiffness and Its Relationship to Exercise Intolerance in Older Patients With Heart Failure and Preserved Ejection Fraction , 2013, Hypertension.

[3]  Daniel Levy,et al.  Aortic stiffness, blood pressure progression, and incident hypertension. , 2012, JAMA.

[4]  D. Harrison,et al.  Inflammation and Mechanical Stretch Promote Aortic Stiffening in Hypertension Through Activation of p38 Mitogen-Activated Protein Kinase , 2013, Circulation research.

[5]  Yuhong Wang,et al.  Current understanding of klotho , 2009, Ageing Research Reviews.

[6]  Zhongjie Sun,et al.  Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation. , 2015, Journal of the American Society of Nephrology : JASN.

[7]  Cynthia A. Reinhart-King,et al.  Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity , 2013, Hypertension.

[8]  N. Fineberg,et al.  Sodium and Volume Sensitivity of Blood Pressure Age and Pressure Change Over Time , 1991, Hypertension.

[9]  Vijay K. Venkatraman,et al.  Aortic Pulse Wave Velocity Predicts Focal White Matter Hyperintensities in a Biracial Cohort of Older Adults , 2013, Hypertension.

[10]  M. Prins,et al.  Carotid Stiffness in Young Adults: A Life-Course Analysis of its Early Determinants The Amsterdam Growth and Health Longitudinal Study , 2012, Hypertension.

[11]  L. Ferrucci,et al.  Longitudinal Trajectories of Arterial Stiffness and the Role of Blood Pressure: The Baltimore Longitudinal Study of Aging , 2013, Hypertension.

[12]  E. Schiffrin,et al.  Role of T Regulatory Lymphocytes in the Pathogenesis of High-Fructose Diet–Induced Metabolic Syndrome , 2013, Hypertension.

[13]  V. Rovella,et al.  Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity , 2013, International journal of endocrinology.

[14]  Zhongjie Sun,et al.  Inhibition of Phosphodiesterase-1 Attenuates Cold-Induced Pulmonary Hypertension , 2013, Hypertension.

[15]  F. Zannad,et al.  Absence of Cardiotrophin 1 Is Associated With Decreased Age-Dependent Arterial Stiffness and Increased Longevity in Mice , 2013, Hypertension.

[16]  C. Lau,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.

[17]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[18]  G. Vilahur,et al.  Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome , 2013, Mediators of inflammation.

[19]  R. Akhtar,et al.  Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction , 2012, Hypertension.

[20]  M. Ryan An update on immune system activation in the pathogenesis of hypertension. , 2013, Hypertension.

[21]  L. Tomlinson,et al.  Elastin Degradation Is Associated With Progressive Aortic Stiffening and All-Cause Mortality in Predialysis Chronic Kidney Disease , 2012, Hypertension.

[22]  B. Alexander,et al.  Renal Denervation Abolishes the Age-Dependent Increase in Blood Pressure in Female Intrauterine Growth-Restricted Rats at 12 Months of Age , 2013, Hypertension.

[23]  Jm Lee,et al.  Prevalence, Awareness, Treatment and Control of Hypertension in Korea , 2013 .

[24]  Yuhong Wang,et al.  Klotho Gene Delivery Prevents the Progression of Spontaneous Hypertension and Renal Damage , 2009, Hypertension.

[25]  J. Mocco,et al.  Altered Inflammatory Response Is Associated With an Impaired Autonomic Input to the Bone Marrow in the Spontaneously Hypertensive Rat , 2014, Hypertension.

[26]  R. Eckel,et al.  Fenofibrate Improves Vascular Endothelial Function by Reducing Oxidative Stress While Increasing Endothelial Nitric Oxide Synthase in Healthy Normolipidemic Older Adults , 2012, Hypertension.

[27]  D. Mari,et al.  Metabolic syndrome in the offspring of centenarians: focus on prevalence, components, and adipokines , 2012, AGE.

[28]  S. Laurent,et al.  Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease , 2012, Hypertension.

[29]  B. Wallin,et al.  Aging Enhances Autonomic Support of Blood Pressure in Women , 2014, Hypertension.

[30]  E. Lubos,et al.  Glutathione Peroxidase-1 Deficiency Potentiates Dysregulatory Modifications of Endothelial Nitric Oxide Synthase and Vascular Dysfunction in Aging , 2014, Hypertension.

[31]  H. Jacob,et al.  CD247 Modulates Blood Pressure by Altering T-Lymphocyte Infiltration in the Kidney , 2014, Hypertension.

[32]  W. Elliott Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2008 .

[33]  B. Pannier,et al.  Metabolic syndrome and age-related progression of aortic stiffness. , 2006, Journal of the American College of Cardiology.

[34]  D. O’Regan,et al.  Body Fat Is Associated With Reduced Aortic Stiffness Until Middle Age , 2013, Hypertension.

[35]  S. Ito,et al.  Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics: Pathophysiological Implication for Microalbuminuria in Hypertension , 2011, Hypertension.

[36]  H. Pavenstädt,et al.  Endothelial Sodium Channels Trigger Endothelial Salt Sensitivity With Aging , 2014, Hypertension.

[37]  D. Webb,et al.  Potential Therapeutic Role of Phosphodiesterase Type 5 Inhibition in Hypertension and Chronic Kidney Disease , 2014, Hypertension.

[38]  D. Seals,et al.  You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging. , 2014, Physiology.

[39]  E. Lakatta,et al.  Calpain-1 Regulation of Matrix Metalloproteinase 2 Activity in Vascular Smooth Muscle Cells Facilitates Age-Associated Aortic Wall Calcification and Fibrosis , 2012, Hypertension.

[40]  S. Ito,et al.  Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta: Potential Implication for Retrograde Embolic Stroke in Hypertension , 2013, Hypertension.

[41]  Gender-Specific Differences in Myocardial Deformation and Aortic Stiffness at Rest and Dobutamine Stress , 2012, Hypertension.

[42]  A. Giobbie-Hurder,et al.  Mechanisms of Premature Vascular Aging in Children With Hutchinson-Gilford Progeria Syndrome , 2012, Hypertension.

[43]  P. Hopkins,et al.  Aldosterone Dysregulation With Aging Predicts Renal Vascular Function and Cardiovascular Risk , 2014, Hypertension.

[44]  K. Wallace,et al.  Preventing Autoimmunity Protects Against the Development of Hypertension and Renal Injury , 2014, Hypertension.

[45]  Rhonda L. Meier,et al.  Relationship Between Sympathetic Baroreflex Sensitivity and Arterial Stiffness in Elderly Men and Women , 2012, Hypertension.

[46]  E. Lakatta,et al.  Chronic Matrix Metalloproteinase Inhibition Retards Age-Associated Arterial Proinflammation and Increase in Blood Pressure , 2012, Hypertension.

[47]  J. Bloodworth Diabetes mellitus and vascular disease. , 1973, Postgraduate medicine.

[48]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[49]  C. Tzourio,et al.  Is hypertension associated with an accelerated aging of the brain? , 2014, Hypertension.

[50]  David Murphy,et al.  Excessive Leukotriene B4 in Nucleus Tractus Solitarii Is Prohypertensive in Spontaneously Hypertensive Rats , 2013, Hypertension.

[51]  Zhongjie Sun,et al.  AAV Delivery of Tumor Necrosis Factor-&agr; Short Hairpin RNA Attenuates Cold-Induced Pulmonary Hypertension and Pulmonary Arterial Remodeling , 2014, Hypertension.

[52]  J. Twisk,et al.  Clustering of Metabolic Syndrome Traits Is Associated With Maladaptive Carotid Remodeling and Stiffening: A 6-Year Longitudinal Study , 2012, Hypertension.